梅芬胺酸对IKs分子复合物的双重作用
Magnus Chan1, Marc Pourrier1, Jodene Eldstrom1
1Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
British journal of pharmacology
|November 9, 2024
概括
梅芬胺酸对心脏IKs通道表现出双重作用,同时起到增强剂和抑制剂的作用. 在KCNQ1/KCNE1通道中的突变可以揭示抑制作用,影响长QT综合征治疗.
科学领域:
- 心血管药理学心血管药理学
- 分子生物学分子生物学
- 离子通道生物物理 离子通道生物物理
背景情况:
- 形成心脏IKs电流的KCNQ1和KCNE1通道的突变与长和短QT综合征有关.
- 梅芬胺酸是一种NSAID,被称为IKs增强剂,为设计新的治疗激动剂提供了潜力.
- 以前的理解表明,美芬胺酸主要是强化IKs电流.
研究的目的:
- 研究美芬胺酸对野生类型 (WT) 和突变KCNQ1/KCNE1通道的双重作用.
- 阐明梅芬胺酸对IKs的增强和抑制的机制.
- 探索这些发现对治疗遗传性心脏病的含义.
主要方法:
- 全细胞补丁电生理学被用来研究梅芬胺酸对tsA201细胞表达的KCNQ1/KCNE1通道的影响.
- 用分子动力学模拟来分析道结构变化和结合相互作用.
- 在野生类型和特定突变道变体上进行了实验.
主要成果:
- 梅芬胺酸在高度下抑制WT IKs,尽管保留了一些强化作用.
- 在KCNQ1/KCNE1通道的突变揭示了低度的梅芬胺酸的抑制作用.
- 抑制涉及毛孔动力学和/或电压传感器-毛孔合的改变,特别是在KCNE1突变体中.
结论:
- 在KCNQ1和KCNE1通道的细胞外接口的结构特征对于确定药物相互作用至关重要.
- 梅芬胺酸的双重作用凸显了IKs通道调节的复杂性.
- 这些发现对长QT综合征突变患者的治疗管理有重大影响.
相关概念视频
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
109
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
109
01:30Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
01:11Fibril-associated Collagen
2.5K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
2.5K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.7K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.7K